This document provides a performance analysis of an algorithm (consolidated) from 2016-2020. It includes key financial metrics like sales, operating profit, net income, debt ratio, and earnings per share. It also evaluates the company's stock price against indication price ranges, and provides a stock price rise probability score and investment opinion.
1. Performance Analysis of Algorithm (consolidated) 003090 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2019.03 2019.06 2019.09 2019.12 2020.03 2020.06
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 10,150 11,240 12,313 11,234 3,186 3,604 3,344 3,523 3,726 3,940 3,414
O-profit 610 845 892 782 258 408 213 196 201 207 269
N-income 346 857 327 510 171 251 167 125 123 120 179
O-rate 6.0 7.5 7.2 6.9 8.1 11.3 6.4 5.6 5.4 5.3 7.8
N-rate 3.4 7.6 2.7 4.6 5.4 7.0 5.0 3.5 3.3 3.1 5.2
ROE 4.0 9.1 3.4 5.5 7.0 8.6 7.4 7.0 6.9 6.9 7.5
Debt-ratio 69.7 64.9 65.1 66.6 67.2 67.0 65.7 62.6 58.7 55.1 65.6
Quick-ratio 179.7 167.2 116.4 154.4 117.1 164.4 168.9 179.2 220.5 272.8 157.4
reserve-ratio 1,749.1 1,958.8 2,054.6 1,920.8 2,095.9 2,169.1 2,208.2 2,245.4 2,298.9 2,354.6 2,179.6
EPS 595 1,474 562 877 294 432 287 215 211 207 307
BPS 14,870 16,155 16,585 15,870 16,800 17,062 17,359 17,650 18,296 18,965 17,218
Dividends 100 100 100 100
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
2020-03-12
Gap
(Indication /
stock)
Color
High price ~ 158 %
High mid ~ 128 %
Mid ~ 98 %
Low mid ~ 67 %
Low price ~ 37 %
Normal
13,281 W 13,281 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 37 3,122 685
22,070 W 22,070 W 19,140 W
19,140 W 19,140 W 16,211 W Evaluation
24,999 W 24,999 W~ 22,070 W
9,690 W
59.016,211 W 16,211 W 13,281 W
Low price
Indication price Range Current stock price Company score
13,281원
16,211원
19,140원
22,070원
24,999원
Low price 9,690원
37.1%
67.3%
97.5%
127.8%
158.%
0.%
20.%
40.%
60.%
80.%
100.%
120.%
140.%
160.%
180.%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
daewoongholdings
Gap
daewoongholdings
2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 003090 Date
Period
Gap
(Indication /
stock)
Color
low price 13,281 W 13,281 W ~ 0 W 37 % -1,411,726 W -106
Low mid 16,211 W 16,211 W ~ 13,281 W 67 % -2,563,222 W -158
Mid 19,140 W 19,140 W ~ 16,211 W 98 % -3,714,719 W -194
High mid 22,070 W 22,070 W ~ 19,140 W 128 % -4,866,215 W All selling
Suggested Purchase
Amount 3,808,963 W
Number of stocks
purchased 393
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 24,999 W 24,999 W~ ~ 22,070 W 158 % -6,017,711 W All selling
2020-03-12
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
9,690 W Low price 50.1 Normal 8,000,000 W
51.0 49.0 45.8 43.3 34.3 52.1
2019.10.16 2019.11.13 2019.12.11 2020.01.13 2020.02.12 2020.03.11
Stock price rise
probability score
A Sector 44.8 48.5 49.5 47.8 48.5 46.0
50.1B Sector 57.1 49.6 42.1 47.8 20.0 58.3
Total average
2019.12.11 2020.01.13 2020.02.12 2020.03.11
Total of
increase rate
Total score
A Sector 8 % 2 % -3 % 1 % -6 %
-2 % 45.0B Sector -15 % -18 % 12 % -139 % 66 %
Total average -4 % -7 % -6 % -27 % 34 %
2019.11.13
45
49 49 48 49 46
57
50
42
48
20
58
51 49
46 43
34
52
0
10
20
30
40
50
60
70
2019.10.16 2019.11.13 2019.12.11 2020.01.13 2020.02.12 2020.03.11
Stock price rise probability score
A sector
B sector
Total average
8% 2% -3% 1% -6%-15% -18%
12%
-139%
66%
-4% -7% -6%
-27%
34%
-150%
-100%
-50%
0%
50%
100%
2019.11.13 2019.12.11 2020.01.13 2020.02.12 2020.03.11
Increase rate of stock price rise
A sector
B sector
Total average
daewoongholdings
3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report